KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Acquisitions (2016 - 2025)

Medtronic (MDT) has disclosed Acquisitions for 12 consecutive years, with $98.0 million as the latest value for Q1 2025.

  • Quarterly Acquisitions rose 88.46% to $98.0 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $287.0 million through Apr 2025, up 36.02% year-over-year, with the annual reading at $98.0 million for FY2025, 53.55% down from the prior year.
  • Acquisitions hit $98.0 million in Q1 2025 for Medtronic, down from $137.0 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $1.2 billion in Q3 2022 to a low of $18.0 million in Q2 2021.
  • Historically, Acquisitions has averaged $321.2 million across 5 years, with a median of $98.0 million in 2025.
  • Biggest five-year swings in Acquisitions: soared 30400.0% in 2021 and later tumbled 96.75% in 2023.
  • Year by year, Acquisitions stood at $91.0 million in 2021, then soared by 642.86% to $676.0 million in 2022, then crashed by 96.75% to $22.0 million in 2023, then skyrocketed by 522.73% to $137.0 million in 2024, then dropped by 28.47% to $98.0 million in 2025.
  • Business Quant data shows Acquisitions for MDT at $98.0 million in Q1 2025, $137.0 million in Q2 2024, and $52.0 million in Q1 2024.